Ypsomed Holding AG

SWX:YPSN Stock Report

Market Cap: CHF 5.5b

Ypsomed Holding Past Earnings Performance

Past criteria checks 1/6

Ypsomed Holding has been growing earnings at an average annual rate of 42.5%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 11.5% per year. Ypsomed Holding's return on equity is 12.9%, and it has net margins of 11.7%.

Key information

42.46%

Earnings growth rate

41.33%

EPS growth rate

Medical Equipment Industry Growth11.07%
Revenue growth rate11.46%
Return on equity12.87%
Net Margin11.68%
Next Earnings Update12 Nov 2025

Recent past performance updates

Ypsomed Holding's (VTX:YPSN) Shareholders May Want To Dig Deeper Than Statutory Profit

May 29
Ypsomed Holding's (VTX:YPSN) Shareholders May Want To Dig Deeper Than Statutory Profit

We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Nov 20
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Recent updates

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Aug 07
Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Jul 24
We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?

Jul 11
Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?

Is Now An Opportune Moment To Examine Ypsomed Holding AG (VTX:YPSN)?

Jun 11
Is Now An Opportune Moment To Examine Ypsomed Holding AG (VTX:YPSN)?

Ypsomed Holding's (VTX:YPSN) Shareholders May Want To Dig Deeper Than Statutory Profit

May 29
Ypsomed Holding's (VTX:YPSN) Shareholders May Want To Dig Deeper Than Statutory Profit

Earnings Miss: Ypsomed Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts

May 24
Earnings Miss: Ypsomed Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts

Returns At Ypsomed Holding (VTX:YPSN) Are On The Way Up

Apr 30
Returns At Ypsomed Holding (VTX:YPSN) Are On The Way Up

Shareholders Should Be Pleased With Ypsomed Holding AG's (VTX:YPSN) Price

Apr 12
Shareholders Should Be Pleased With Ypsomed Holding AG's (VTX:YPSN) Price

What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

Feb 23
What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Jan 23
We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Jan 09
Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Returns On Capital Are Showing Encouraging Signs At Ypsomed Holding (VTX:YPSN)

Dec 23
Returns On Capital Are Showing Encouraging Signs At Ypsomed Holding (VTX:YPSN)
User avatar

GLP-1 Partnerships And Capacity Expansion To Drive Revenue Growth And Boost Margins

Ypsomed's shift to a B2B model and local manufacturing may streamline operations, improve focus, and reduce geopolitical risks, enhancing margins and earnings.

We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Nov 20
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

Nov 17
Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

Revenue & Expenses Breakdown

How Ypsomed Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SWX:YPSN Revenue, expenses and earnings (CHF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 257498812634
31 Dec 246838112132
30 Sep 24617741160
30 Jun 24583761120
31 Mar 245487810830
31 Dec 235297510715
30 Sep 23509721050
30 Jun 23503621040
31 Mar 23497511030
31 Dec 2249241990
30 Sep 2248631950
30 Jun 2247627920
31 Mar 2246523890
30 Sep 214276970
30 Jun 214156960
31 Mar 214046940
30 Sep 2040311870
30 Jun 2039911880
31 Mar 2039412890
31 Dec 1939012900
30 Sep 1938612900
30 Jun 1942036900
31 Mar 1945460900
31 Dec 1848372900
30 Sep 1851185890
30 Jun 1848968860
31 Mar 1846652820
31 Dec 1744250780
30 Sep 1741847750
30 Jun 1740447740
31 Mar 1739046730
31 Dec 1637745700
30 Sep 1636543670
30 Jun 1635139640
31 Mar 1633736620
31 Dec 1532631610
30 Sep 1531626600
30 Jun 1531122600
31 Mar 1530719600
31 Dec 1430019590
30 Sep 1429318580

Quality Earnings: YPSN has a high level of non-cash earnings.

Growing Profit Margin: YPSN's current net profit margins (11.7%) are lower than last year (14.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: YPSN's earnings have grown significantly by 42.5% per year over the past 5 years.

Accelerating Growth: YPSN's earnings growth over the past year (11.7%) is below its 5-year average (42.5% per year).

Earnings vs Industry: YPSN earnings growth over the past year (11.7%) did not outperform the Medical Equipment industry 16%.


Return on Equity

High ROE: YPSN's Return on Equity (12.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/18 11:55
End of Day Share Price 2025/08/18 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ypsomed Holding AG is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gaurav JainBarclays
Hugo SolvetBNP Paribas Exane
Curtis MoilesBNP Paribas Exane